Essilor reveals Vision-R700 phoropter

The device offers a faster, socially distanced refraction, which the company suggests could support practices operating under COVID-19 restrictions

essilor phoropter
Essilor has launched the new Vision-R700 phoropter, which it suggests can offer a faster, socially distanced refraction, while also providing repeatable results.  

The company suggests this device could be particularly beneficial for eye care professionals (ECPs) practising during the pandemic.

To help reduce the length of an eye examination, the new device can obtain a refraction in three minutes, whilst still gaining accurate and repeatable results, the company explained.

The Vision-R700 incorporates a multiple increment algorithm, as well as a series of patient-specific smart programmes to shorten the process and provide a 0.25D refraction.

This includes the Digital Infinite Refraction process, which automatically compensates for the effect that any change in sphere, cylinder and axis had on one of the other dimensions. The company suggests that the continuous compensation ensures accuracy and reduces the need for estimated lens compensation.

Essilor phoropter
Essilor has launched its Vision-R700

While the device shares the features of the existing Vision-R800 model, by halving the measurement stages the company suggests it has cut the testing time in half.

The device can also be operated from up to seven meters away, supporting social distancing, and is easier to clean than a traditional trial frame.

Instruments director, Paul Cumber, explained that the device was designed for practices who see a high number of patients, or would be an ideal upgrade for practices using a trial frame and looking for a new phoropter for faster refractions.

“By reducing chair time, the new phoropter could help practices see up to two extra patients a day,” Mr Cumber said, adding: “This is invaluable amongst current COVID-19 restrictions and ECPs having to cut back on appointments because of social distancing and lengthy cleaning regimes.”

Essilor suggests the Vision-R700 can help deliver a smoother refraction process, utilising a module which allows for smaller incremental power changes. The changes are quick and quiet, the company said, which enables the patient to see the difference more easily, while there is also an option to present old versus new prescriptions to support conversations.

Developed with a focus on ease of use, the device can guide the practitioner through the process, and aims to make the eye examination less labour intensive for the patient and eye care professional.

“Until now, the only way to shorten the traditional procedure of bracketing sphere, cylinder and axis independently was by cutting crucial steps. This leads to bigger variances and an estimation of the prescription,” Mr Cumber said.

He continued: “Using the phoropter will help practices obtain repeatable results to eliminate the discrepancy you can get with a traditional subjective refraction.”